{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:29Z","timestamp":1794047489533,"version":"4.8.0"},"reference-count":55,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"12","license":[{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Adult T-cell leukemia-lymphoma (ATLL) is an aggressive malignancy driven by human T-cell leukemia virus type 1 (HTLV-1). Although patients from the Western hemisphere (Afro-Caribbean and South American) face worse prognoses, our understanding of ATLL molecular drivers derives mostly from Japanese studies. We performed multi-omic analyses to elucidate the genomic landscape of ATLL in Western cohorts. Recurrent deletions and\/or damaging mutations involving FOXO3, ANKRD11, DGKZ, and PTPN6 implicate these genes as potential tumor suppressors. RNA-sequencing, published functional data and in vitro assays support the roles of ANKRD11 and FOXO3 as regulators of T-cell proliferation and apoptosis in ATLL, respectively. Survival data suggest that ANKRD11 mutation may confer a worse prognosis. Japanese and Western cohorts, in addition to acute and lymphomatous subtypes, demonstrated distinct molecular patterns. GATA3 deletion was associated with chronic cases with unfavorable outcomes. IRF4 and CARD11 mutations frequently emerged in relapses after interferon therapy. Our findings reveal novel putative ATLL driver genes and clinically relevant differences between Japanese and Western ATLL patients.<\/jats:p>","DOI":"10.3324\/haematol.2024.285233","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T11:25:55Z","timestamp":1723116355000},"page":"4021-4039","source":"Crossref","is-referenced-by-count":10,"title":["Distinctive genomic features of human T-lymphotropic virus type 1-related adult T-cell leukemia-lymphoma in Western populations"],"prefix":"10.3324","volume":"109","author":[{"given":"Caroline S.","family":"Myers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Barrionuevo","family":"Cornejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Pongas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoc L.","family":"Toomey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Sanches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Battistella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Pulitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristopher A.","family":"Moskaluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govind","family":"Bhagat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Ofori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Davick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Octavio","family":"Servitje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Miyashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fina","family":"Climent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley","family":"Ringbloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Duenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro Casavilca","family":"Zambrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Malpica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brady E.","family":"Beltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denisse","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Brites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaehyuk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro A.","family":"Gru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"key":"70014","doi-asserted-by":"crossref","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980; 77(12):7415-7419.","DOI":"10.1073\/pnas.77.12.7415"},{"key":"70015","doi-asserted-by":"crossref","unstructured":"Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012; 3:388.","DOI":"10.3389\/fmicb.2012.00388"},{"key":"70016","doi-asserted-by":"crossref","unstructured":"Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol. 1991; 79(3):428-437.","DOI":"10.1111\/j.1365-2141.1991.tb08051.x"},{"key":"70017","doi-asserted-by":"crossref","unstructured":"Cook LB, Fuji S, Hermine O. Revised adult T-cell leukemialymphoma International Consensus Meeting Report. J Clin Oncol. 2019; 37(8):677-687.","DOI":"10.1200\/JCO.18.00501"},{"key":"70018","doi-asserted-by":"crossref","unstructured":"Ishitsuka K, Tamura K. Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. Lancet Oncol. 2014; 15(11):e517-526.","DOI":"10.1016\/S1470-2045(14)70202-5"},{"key":"70019","doi-asserted-by":"crossref","unstructured":"Katsuya H, Ishitsuka K, Utsunomiya A. Treatment and survival among 1594 patients with ATL. Blood. 2015; 126(24):2570-2577.","DOI":"10.1182\/blood-2015-03-632489"},{"key":"70020","doi-asserted-by":"crossref","unstructured":"Imaizumi Y, Iwanaga M, Nosaka K. Prognosis of patients with adult T-cell leukemia\/lymphoma in Japan: a nationwide hospital-based study. Cancer Sci. 2020; 111(12):4567-4580.","DOI":"10.1111\/cas.14658"},{"key":"70021","doi-asserted-by":"crossref","unstructured":"Subramaniam JM, Whiteside G, McKeage K, Croxtall JC. Mogamulizumab: first global approval. Drugs. 2012; 72(9):1293-1298.","DOI":"10.2165\/11631090-000000000-00000"},{"key":"70022","doi-asserted-by":"crossref","unstructured":"Malpica L, Pimentel A, Reis IM. Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States. Blood Adv. 2018; 2(6):607-620.","DOI":"10.1182\/bloodadvances.2017011106"},{"key":"70023","doi-asserted-by":"crossref","unstructured":"Shah UA, Shah N, Qiao B. Epidemiology and survival trend of adult T-cell leukemia\/lymphoma in the United States. Cancer. 2020; 126(3):567-574.","DOI":"10.1002\/cncr.32556"},{"key":"70024","doi-asserted-by":"crossref","unstructured":"Kataoka K, Iwanaga M, Yasunaga JI. Prognostic relevance of integrated genetic profiling in adult T-cell leukemia\/ lymphoma. Blood. 2018; 131(2):215-225.","DOI":"10.1182\/blood-2017-01-761874"},{"key":"70025","doi-asserted-by":"crossref","unstructured":"Kataoka K, Nagata Y, Kitanaka A. Integrated molecular analysis of adult T cell leukemia\/lymphoma. Nat Genet. 2015; 47(11):1304-1315.","DOI":"10.1038\/ng.3428"},{"key":"70026","doi-asserted-by":"crossref","unstructured":"Kogure Y, Kameda T, Koya J. Whole-genome landscape of adult T-cell leukemia\/lymphoma. Blood. 2022; 139(7):967-982.","DOI":"10.1182\/blood.2021013568"},{"key":"70027","doi-asserted-by":"crossref","unstructured":"Marcais A, Lhermitte L, Artesi M. Targeted deep sequencing reveals clonal and subclonal mutational signatures in adult T-cell leukemia\/lymphoma and defines an unfavorable indolent subtype. Leukemia. 2021; 35(3):764-776.","DOI":"10.1038\/s41375-020-0900-3"},{"key":"70028","doi-asserted-by":"crossref","unstructured":"Shah UA, Chung EY, Giricz O. North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies. Blood. 2018; 132(14):1507-1518.","DOI":"10.1182\/blood-2018-01-824607"},{"key":"70029","doi-asserted-by":"crossref","unstructured":"Alvarez-Gomez RM, De la Fuente-Hernandez MA, HerreraMontalvo L, Hidalgo-Miranda A. Challenges of diagnostic genomics in Latin America. Curr Opin Genet Dev. 2021; 66:101-109.","DOI":"10.1016\/j.gde.2020.12.010"},{"key":"70030","doi-asserted-by":"crossref","unstructured":"Spratt DE, Chan T, Waldron L. Racial\/ethnic disparities in genomic sequencing. JAMA Oncol. 2016; 2(8):1070-1074.","DOI":"10.1001\/jamaoncol.2016.1854"},{"key":"70031","doi-asserted-by":"crossref","unstructured":"Zhang J, Bajari R, Andric D. The International Cancer Genome Consortium data portal. Nat Biotechnol. 2019; 37(4):367-369.","DOI":"10.1038\/s41587-019-0055-9"},{"key":"70032","doi-asserted-by":"crossref","unstructured":"Grossman RL, Heath AP, Ferretti V. Toward a shared vision for cancer genomic data. N Engl J Med. 2016; 375(12):1109-1112.","DOI":"10.1056\/NEJMp1607591"},{"key":"70033","unstructured":"Therneau T. A package for survival analysis in R 2022 [R package version 3.3-1]. 2023."},{"key":"70034","doi-asserted-by":"crossref","unstructured":"Canisius S, Martens JW, Wessels LF. A novel independence test for somatic alterations in cancer shows that biology drives mutual exclusivity but chance explains most co-occurrence. Genome Biol. 2016; 17(1):261.","DOI":"10.1186\/s13059-016-1114-x"},{"key":"70035","doi-asserted-by":"crossref","unstructured":"Romanel A, Zhang T, Elemento O, Demichelis F. EthSEQ: ethnicity annotation from whole exome sequencing data. Bioinformatics. 2017; 33(15):2402-2404.","DOI":"10.1093\/bioinformatics\/btx165"},{"key":"70036","doi-asserted-by":"crossref","unstructured":"Daniels J, Doukas PG, Escala MEM. Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas. Nat Commun. 2020; 11(1):1806.","DOI":"10.1038\/s41467-020-15572-7"},{"key":"70037","doi-asserted-by":"crossref","unstructured":"Park J, Daniels J, Wartewig T. Integrated genomic analyses of cutaneous T cell lymphomas reveal the molecular bases for disease heterogeneity. Blood. 2021; 138(14):1225-1236.","DOI":"10.1182\/blood.2020009655"},{"key":"70038","doi-asserted-by":"crossref","unstructured":"Park J, Yang J, Wenzel AT. Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E). Blood. 2017; 130(12):1430-1440.","DOI":"10.1182\/blood-2017-02-768234"},{"key":"70039","doi-asserted-by":"crossref","unstructured":"Choi J, Goh G, Walradt T. Genomic landscape of cutaneous T cell lymphoma. Nat Genet. 2015; 47(9):1011-1019.","DOI":"10.1038\/ng.3356"},{"key":"70040","doi-asserted-by":"crossref","unstructured":"Tate JG, Bamford S, Jubb HC. COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res. 2019; 47(D1):D941-D947.","DOI":"10.1093\/nar\/gky1015"},{"key":"70041","doi-asserted-by":"crossref","unstructured":"Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science. 2013; 339(6127):1546-1558.","DOI":"10.1126\/science.1235122"},{"key":"70042","doi-asserted-by":"crossref","unstructured":"Foster JM, Oumie A, Togneri FS. Cross-laboratory validation of the OncoScan(R) FFPE Assay, a multiplex tool for whole genome tumour profiling. BMC Med Genomics. 2015; 8:5.","DOI":"10.1186\/s12920-015-0079-z"},{"key":"70043","doi-asserted-by":"crossref","unstructured":"Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011; 12(4):R41.","DOI":"10.1186\/gb-2011-12-4-r41"},{"key":"70044","doi-asserted-by":"crossref","unstructured":"Boons E, Nogueira TC, Dierckx T. XPO1 inhibitors represent a novel therapeutic option in adult T-cell leukemia, triggering p53-mediated caspase-dependent apoptosis. Blood Cancer J. 2021; 11(2):27.","DOI":"10.1038\/s41408-021-00409-3"},{"key":"70045","doi-asserted-by":"crossref","unstructured":"Uchida Y, Yoshimitsu M, Hachiman M. RLTPR Q575E: a novel recurrent gain-of-function mutation in patients with adult T-cell leukemia\/lymphoma. Eur J Haematol. 2021; 106(2):221-229.","DOI":"10.1111\/ejh.13540"},{"key":"70046","doi-asserted-by":"crossref","unstructured":"Nakagawa M, Schmitz R, Xiao W. Gain-of-function CCR4 mutations in adult T cell leukemia\/lymphoma. J Exp Med. 2014; 211(13):2497-2505.","DOI":"10.1084\/jem.20140987"},{"key":"70047","doi-asserted-by":"crossref","unstructured":"Schmidt R, Steinhart Z, Layeghi M. CRISPR activation and interference screens decode stimulation responses in primary human T cells. Science. 2022; 375(6580)","DOI":"10.1126\/science.abj4008"},{"key":"70048","doi-asserted-by":"crossref","unstructured":"Shifrut E, Carnevale J, Tobin V. Genome-wide CRISPR screens in primary human T cells reveal key regulators of immune function. Cell. 2018; 175(7):1958-1971.","DOI":"10.1016\/j.cell.2018.10.024"},{"key":"70049","doi-asserted-by":"crossref","unstructured":"Noll JE, Jeffery J, Al-Ejeh F. Mutant p53 drives multinucleation and invasion through a process that is suppressed by ANKRD11. Oncogene. 2012; 31(23):2836-2848.","DOI":"10.1038\/onc.2011.456"},{"key":"70050","doi-asserted-by":"crossref","unstructured":"Sirmaci A, Spiliopoulos M, Brancati F. Mutations in ANKRD11 cause KBG syndrome, characterized by intellectual disability, skeletal malformations, and macrodontia. Am J Hum Genet. 2011; 89(2):289-294.","DOI":"10.1016\/j.ajhg.2011.06.007"},{"key":"70051","doi-asserted-by":"crossref","unstructured":"Chen SS, Hu Z, Zhong XP. Diacylglycerol kinases in T cell tolerance and effector function. Front Cell Dev Biol. 2016; 4:130.","DOI":"10.3389\/fcell.2016.00130"},{"key":"70052","doi-asserted-by":"crossref","unstructured":"Birnbaum ME, Berry R, Hsiao YS. Molecular architecture of the alphabeta T cell receptor-CD3 complex. Proc Natl Acad Sci U S A. 2014; 111(49):17576-17581.","DOI":"10.1073\/pnas.1420936111"},{"key":"70053","doi-asserted-by":"crossref","unstructured":"Plas DR, Johnson R, Pingel JT. Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling. Science. 1996; 272(5265):1173-1176.","DOI":"10.1126\/science.272.5265.1173"},{"key":"70054","doi-asserted-by":"crossref","unstructured":"Ouyang W, Beckett O, Ma Q, Paik JH, DePinho RA, Li MO. Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat Immunol. 2010; 11(7):618-627.","DOI":"10.1038\/ni.1884"},{"key":"70055","doi-asserted-by":"crossref","unstructured":"Liu Y, Ao X, Ding W. Critical role of FOXO3a in carcinogenesis. Mol Cancer. 2018; 17(1):104.","DOI":"10.1186\/s12943-018-0856-3"},{"key":"70056","doi-asserted-by":"crossref","unstructured":"Olagnier D, Sze A, Bel Hadj S. HTLV-1 Tax-mediated inhibition of FOXO3a activity is critical for the persistence of terminally differentiated CD4+ T cells. PLoS Pathog. 2014; 10(12):e1004575.","DOI":"10.1371\/journal.ppat.1004575"},{"key":"70057","doi-asserted-by":"crossref","unstructured":"Tanaka-Nakanishi A, Yasunaga J, Takai K, Matsuoka M. HTLV-1 bZIP factor suppresses apoptosis by attenuating the function of FoxO3a and altering its localization. Cancer Res. 2014; 74(1):188-200.","DOI":"10.1158\/0008-5472.CAN-13-0436"},{"key":"70058","doi-asserted-by":"crossref","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008; 9:559.","DOI":"10.1186\/1471-2105-9-559"},{"key":"70059","doi-asserted-by":"crossref","unstructured":"Li Z, Bridges B, Olson J, Weinman SA. The interaction between acetylation and serine-574 phosphorylation regulates the apoptotic function of FOXO3. Oncogene. 2017; 36(13):1887-1898.","DOI":"10.1038\/onc.2016.359"},{"key":"70060","doi-asserted-by":"crossref","unstructured":"Phillips AA, Fields PA, Hermine O. Mogamulizumab versus investigator\u2019s choice of chemotherapy regimen in relapsed\/ refractory adult T-cell leukemia\/lymphoma. Haematologica. 2019; 104(5):993-1003.","DOI":"10.3324\/haematol.2018.205096"},{"key":"70061","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Chronic lymphocytic leukemia\/small lymphocytic lymphoma version 2.2022. 2022."},{"key":"70062","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. B-cell lymphomas. 2022."},{"key":"70063","doi-asserted-by":"crossref","unstructured":"Richardson NC, Kasamon Y, Pazdur R, Gormley N. The saga of PI3K inhibitors in haematological malignancies: survival is the ultimate safety endpoint. Lancet Oncol. 2022; 23(5):563-566.","DOI":"10.1016\/S1470-2045(22)00200-5"},{"key":"70064","doi-asserted-by":"crossref","unstructured":"Horwitz SM, Koch R, Porcu P. Activity of the PI3K-\u03b4,\u03b3 inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma. Blood. 2018; 131(8):888-898.","DOI":"10.1182\/blood-2017-08-802470"},{"key":"70065","doi-asserted-by":"crossref","unstructured":"Katsuya H, Cook LBM, Rowan AG, Satou Y, Taylor GP, Bangham CRM. Phosphatidylinositol 3-kinase-\u03b4 (PI3K-\u03b4) is a potential therapeutic target in adult T-cell leukemia-lymphoma. Biomark Res. 2018; 6:24.","DOI":"10.1186\/s40364-018-0138-7"},{"key":"70066","doi-asserted-by":"crossref","unstructured":"Yu F, Sharma S, Edwards J, Feigenbaum L, Zhu J. Dynamic expression of transcription factors T-bet and GATA-3 by regulatory T cells maintains immunotolerance. Nat Immunol. 2015; 16(2):197-206.","DOI":"10.1038\/ni.3053"},{"key":"70067","doi-asserted-by":"crossref","unstructured":"Yamagata T, Nishida J, Tanaka S. A novel interferon regulatory factor family transcription factor, ICSAT\/Pip\/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol Cell Biol. 1996; 16(4):1283-1294.","DOI":"10.1128\/MCB.16.4.1283"},{"key":"70068","doi-asserted-by":"crossref","unstructured":"Ramos JC, Ruiz P Jr, Ratner L. IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia\/lymphoma. Blood. 2007; 109(7):3060-3068.","DOI":"10.1182\/blood-2006-07-036368"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.285233\/77458","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.285233\/77838","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11716\/77458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:07:08Z","timestamp":1794046028000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2024.285233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":55,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2024.285233","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,8]]}}}